The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE e{open}4 carriers

Neuroscience Letters

Volumn 482, Issue 3, 2010, Pages 260-263

  Wang, Min ^a,b   Jia, Jianping ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Alzheimer's disease; IL 6; Polymorphism; Promoter

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 6; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SCREENING;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; INTERLEUKIN-6; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 77955918642     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.051     Document Type: Article

References (36)

1. Aisen P.S. Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontology 1997, 43:143-149.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
3. Arosio B., Trabattoni D., Galimberti L., Bucciarelli P., Fasano F., Calabresi C., Cazzullo C.L., Vergani C., Annoni G., Clerici M. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 2004, 25:1009-1015.
4. Bauer J., Strauss S., Volk B., Berger M. IL-6-mediated events in Alzheimer's disease pathology. Immunol. Today 1991, 12:422.
5. Braida D., Sacerdote P., Panerai A.E., Bianchi M., Aloisi A.M., Iosue S., Sala M. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav. Brain Res. 2004, 153:423-429.
6. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., Lowe G.D., Humphries S.E. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001, 21:1458-1463.
7. Campbell I.L., Stalder A.K., Chiang C.S., Bellinger R., Heyser C.J., Steffensen S., Masliah E., Powell H.C., Gold L.H., Henriksen S.J., Siggins G.R. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry 1997, 2:125-129.
8. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Capurso A., Panza F. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp. Gerontol. 2004, 39:1567-1573.
9. Castell J.V., Andus T., Kunz D., Heinrich P.C. Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann. N.Y. Acad. Sci. 1989, 557:87-99.
10. Colton C.A., Needham L.K., Brown C., Cook D., Rasheed K., Burke J.R., Strittmatter W.J., Schmechel D.E., Vitek M.P. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J. Neuroimmunol. 2004, 147:62-67.
11. Combarros O., Alvarez-Arcaya A., Sanchez-Guerra M., Infante J., Berciano J. Candidate gene association studies in sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002, 14:41-54.
12. Depboylu C., Lohmuller F., Gocke P., Du Y., Zimmer R., Gasser T., Klockgether T., Dodel R.C. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2004, 17:170-173.
13. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 2004, 61:668-672.
14. Finch C.E., Morgan T.E. Systemic inflammation, infection, APOE alleles, and Alzheimer disease: a position paper. Curr. Alzheimer Res. 2007, 4:185-189.
15. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
16. He M.X., Yang W.L., Zhang M.M., Lian Y.J., Hua H.Y., Zeng J.S., Zhang L.R. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol. Sci. 2009.
17. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1500-1505.
18. Jofre-Monseny L., Loboda A., Wagner A.E., Huebbe P., Boesch-Saadatmandi C., Jozkowicz A., Minihane A.M., Dulak J., Rimbach G. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 2007, 357:319-324.
19. Koivisto A.M., Helisalmi S., Pihlajamaki J., Moilanen L., Kuusisto J., Laakso M., Hiltunen M., Keijo K., Hanninen T., Helkala E.L., Kervinen K., Kesaniemi Y.A., Soininen H. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J. Neurogenet. 2005, 19:155-161.
20. Licastro F., Grimaldi L.M., Bonafe M., Martina C., Olivieri F., Cavallone L., Giovanietti S., Masliah E., Franceschi C. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 2003, 24:921-926.
21. Lim C.S., Zheng S., Kim Y.S., Ahn C., Han J.S., Kim S., Lee J.S., Chae D.W. The -174G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002, 19:52-54.
22. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5644-5651.
23. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
24. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
25. Nakajima T., Ota N., Yoshida H., Watanabe S., Suzuki T., Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun. 1999, 1:115-119.
26. Nishimura M., Sakamoto T., Kaji R., Kawakami H. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci. Lett. 2004, 368:140-143.
27. Papassotiropoulos A., Hock C., Nitsch R.M. Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol. Aging 2001, 22:863-871.
28. Quintanilla R.A., Orellana D.I., Gonzalez-Billault C., Maccioni R.B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 2004, 295:245-257.
29. Selmaj K.W., Farooq M., Norton W.T., Raine C.S., Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 1990, 144:129-135.
30. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
31. Tsai M.S., Tangalos E.G., Petersen R.C., Smith G.E., Schaid D.J., Kokmen E., Ivnik R.J., Thibodeau S.N. Apolipoprotein E: risk factor for Alzheimer disease. Am. J. Hum. Genet. 1994, 54:643-649.
32. Tsoi L.M., Wong K.Y., Liu Y.M., Ho Y.Y. Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6 in macrophages. Arch. Biochem. Biophys. 2007, 460:33-40.
33. van Oijen M., Arp P.P., de Jong F.J., Hofman A., Koudstaal P.J., Uitterlinden A.G., Breteler M.M. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam study. Neurosci. Lett. 2006, 402:113-117.
34. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002, 59:371-378.
35. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
36. Wong L.Y., Leung R.Y., Ong K.L., Cheung B.M. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension. J. Hum. Hypertens. 2007, 21:875-882.